344 related articles for article (PubMed ID: 36735185)
1. Stem Cell-Based Therapeutic Approaches in Genetic Diseases.
Aslan A; Yuka SA
Adv Exp Med Biol; 2023; 1436():19-53. PubMed ID: 36735185
[TBL] [Abstract][Full Text] [Related]
2. Applications of Genome Editing Tools in Stem Cells Towards Regenerative Medicine: An Update.
Kues WA; Kumar D; Selokar NL; Talluri TR
Curr Stem Cell Res Ther; 2022; 17(3):267-279. PubMed ID: 34819011
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in genome editing of stem cells for drug discovery and therapeutic application.
Lee J; Bayarsaikhan D; Bayarsaikhan G; Kim JS; Schwarzbach E; Lee B
Pharmacol Ther; 2020 May; 209():107501. PubMed ID: 32061705
[TBL] [Abstract][Full Text] [Related]
4. The application of the CRISPR-Cas9 genome editing machinery in food and agricultural science: Current status, future perspectives, and associated challenges.
Eş I; Gavahian M; Marti-Quijal FJ; Lorenzo JM; Mousavi Khaneghah A; Tsatsanis C; Kampranis SC; Barba FJ
Biotechnol Adv; 2019; 37(3):410-421. PubMed ID: 30779952
[TBL] [Abstract][Full Text] [Related]
5. Evolution in crop improvement approaches and future prospects of molecular markers to CRISPR/Cas9 system.
Dheer P; Rautela I; Sharma V; Dhiman M; Sharma A; Sharma N; Sharma MD
Gene; 2020 Aug; 753():144795. PubMed ID: 32450202
[TBL] [Abstract][Full Text] [Related]
6. Targeted Gene Editing in Human Pluripotent Stem Cells Using Site-Specific Nucleases.
Merkert S; Martin U
Adv Biochem Eng Biotechnol; 2018; 163():169-186. PubMed ID: 29124278
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Genome Editing and In Vivo Delivery.
Ramirez-Phillips AC; Liu D
AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
[TBL] [Abstract][Full Text] [Related]
8. Efficient Genome Editing in Induced Pluripotent Stem Cells with Engineered Nucleases In Vitro.
Termglinchan V; Seeger T; Chen C; Wu JC; Karakikes I
Methods Mol Biol; 2017; 1521():55-68. PubMed ID: 27910041
[TBL] [Abstract][Full Text] [Related]
9. Genome Editing in Stem Cells for Disease Therapeutics.
Song M; Ramakrishna S
Mol Biotechnol; 2018 Apr; 60(4):329-338. PubMed ID: 29516417
[TBL] [Abstract][Full Text] [Related]
10. Genome engineering tools for building cellular models of disease.
Lin J; Musunuru K
FEBS J; 2016 Sep; 283(17):3222-31. PubMed ID: 27218233
[TBL] [Abstract][Full Text] [Related]
11. CRISPR Genome Engineering for Human Pluripotent Stem Cell Research.
Chaterji S; Ahn EH; Kim DH
Theranostics; 2017; 7(18):4445-4469. PubMed ID: 29158838
[TBL] [Abstract][Full Text] [Related]
12. Understanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells.
Lee BC; Lozano RJ; Dunbar CE
Mol Ther; 2021 Nov; 29(11):3205-3218. PubMed ID: 34509667
[TBL] [Abstract][Full Text] [Related]
13. Genome Editing in Human Pluripotent Stem Cells.
Carlson-Stevermer J; Saha K
Methods Mol Biol; 2017; 1590():165-174. PubMed ID: 28353269
[TBL] [Abstract][Full Text] [Related]
14. Genome centric engineering using ZFNs, TALENs and CRISPR-Cas9 systems for trait improvement and disease control in Animals.
Wani AK; Akhtar N; Singh R; Prakash A; Raza SHA; Cavalu S; Chopra C; Madkour M; Elolimy A; Hashem NM
Vet Res Commun; 2023 Jan; 47(1):1-16. PubMed ID: 35781172
[TBL] [Abstract][Full Text] [Related]
15. Applications of genome editing by programmable nucleases to the metabolic engineering of secondary metabolites.
Leitão AL; Costa MC; Enguita FJ
J Biotechnol; 2017 Jan; 241():50-60. PubMed ID: 27845165
[TBL] [Abstract][Full Text] [Related]
16. Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles.
Yu KR; Natanson H; Dunbar CE
Hum Gene Ther; 2016 Oct; 27(10):729-740. PubMed ID: 27483988
[TBL] [Abstract][Full Text] [Related]
17. Application of different types of CRISPR/Cas-based systems in bacteria.
Liu Z; Dong H; Cui Y; Cong L; Zhang D
Microb Cell Fact; 2020 Sep; 19(1):172. PubMed ID: 32883277
[TBL] [Abstract][Full Text] [Related]
18. Editing the genome of common cereals (Rice and Wheat): techniques, applications, and industrial aspects.
Das N; Ghosh Dhar D; Dhar P
Mol Biol Rep; 2023 Jan; 50(1):739-747. PubMed ID: 36309609
[TBL] [Abstract][Full Text] [Related]
19. Chemical and Biological Approaches to Interrogate off-Target Effects of Genome Editing Tools.
Lei Z; Meng H; Zhuang Y; Zhu Q; Yi C
ACS Chem Biol; 2023 Feb; 18(2):205-217. PubMed ID: 36731114
[TBL] [Abstract][Full Text] [Related]
20. Gene editing tools: state-of-the-art and the road ahead for the model and non-model fishes.
Barman HK; Rasal KD; Chakrapani V; Ninawe AS; Vengayil DT; Asrafuzzaman S; Sundaray JK; Jayasankar P
Transgenic Res; 2017 Oct; 26(5):577-589. PubMed ID: 28681201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
